The Glu298Asp polymorphism in the NOS3 gene and the risk of prostate cancer
The Glu298Asp polymorphism in the NOS3 gene has been implicated as a risk factor for prostate cancer. To date, several studies have evaluated the associations between the Glu298Asp polymorphism and prostate cancer risk; however, the results were inconclusive. The aim of the current study was to perform a meta-analysis to investigate the association between the polymorphism and the risk of prostate cancer. A total of 3,206 cases and 3,880 controls from eight case-control studies were included for data synthesis. The overall results suggested no significant association between the polymorphism and the risk of prostate cancer (OR=1.01, 95 % CI=0.92–1.11, p = 0.83 for Asp/Asp+Glu/Asp vs. Glu/Glu). In the stratified analysis according to ethnicity, no significant associations were observed in Asians and Europeans. The current meta-analysis suggested that the Glu298Asp polymorphism of the NOS3 gene might not contribute to the risk of prostate cancer.
KeywordsProstate cancer Polymorphism NOS3 Meta-analysis
Conflict of Interest
- 2.Teixeira AL, Gomes M, Nogueira A, Azevedo AS, Assis J, Dias F, et al. Improvement of a predictive model of castration-resistant prostate cancer: functional genetic variants in TGFbeta1 signaling pathway modulation. PLoS ONE. 2013;8(8):e72419. doi: 10.1371/journal.pone.0072419.CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Cheng ZG, Zhou W, Tao ZH, Chen W. Associaiton of endothelial nitric oxide cynthase gene polymorphism with prostae cancer. Zhong Guo Nan Ke Xue Za Zhi. 2011;25(7):18–21.Google Scholar